SRI Biosciences provides internationally recognized expertise and services through all stages of drug discovery and development. With state-of- the-art equipment and biomedical research facilities, we offer turnkey and customized In Vivo R&D Services, including animal models for research and drug discovery, identification of targets and mechanisms of action, efficacy, pharmacology and pharmacokinetics, and safety. Contact us through the form below for more information or to discuss your requirements.

Contract Research Services
Outsourcing R&D can play an important role in enhancing capacity and strengthening expertise. SRI Biosciences partners with clients to seamlessly integrate basic research, drug discovery, and nonclinical and clinical development.
We provide research and services that span all stages of drug discovery and preclinical development leading to human clinical trials. Your goals are our priority. We combine outstanding customer service with a commitment to scientific excellence through best-in- class R&D.
Learn how our specialized services for contract R&D can help you improve operating and infrastructure efficiency. Browse the services highlighted here, or contact us through the form below to discuss your specific needs.
Cognitive Science Research
SRI's translational neurosciences research laboratory provides investigative studies of complex cognitive processes utilizing customized, validated models that support research from rodent studies to human clinical trials. SRI manages a state-of-the-art laboratory that employs translational models to better understand complex biological and neurological disease mechanisms—and ultimately accelerate and minimize drug discovery risks and development to accelerate time to market for new treatments.
Circulating Tumor Cell Testing Services
Our FASTcell™ testing services deliver rapid, sensitive, and specific characterization of CTCs in whole blood samples, giving cancer clinical researchers a vital new analytical testing tool. The underlying technology can accurately characterize CTCs from a number of cancers (including breast, lung, prostate, colorectal, and leukemia) through a wide array of customizable cancer-specific biomarkers.
Cancer Efficacy Evaluation Services
SRI’s in vivo efficacy testing services include a broad range of xenograft tumor models in mice, including SRI's customized patient derived cellular xenograft model - PDCellX™. PDCellX provides a more predictive model of human response in a variety of tissues and provides advantages such as custom biomarker and pharmacodynamic endpoint analysis and shorter tumor study timelines compared to standard PDX models.
Medicinal Chemistry Services
With extensive applied knowledge and experience, our medicinal chemistry and strategic guidance services can be applied at every stage of the drug discovery process (hit validation, hit-to-lead, and lead optimization) to help create and deliver effective candidates for further preclinical or clinical evaluations. Client investigators can also request specific services, such as custom synthesis and validated testing for physico-chemical, biological, and pharmacokinetic profiling, as well as custom assay development.
Formulation and Manufacturing (CMC) Services
SRI's preformulation and formulation services help optimize safety and efficacy in drug development. Our approach is customized according to each client’s program needs. Our drug formulation experience ranges from preparation of dose formulations for preclinical in vitro and in vivo safety studies, to design and manufacture of finished drug product dosage forms for clinical trials.
Phase I Clinical Trial Services
SRI is pioneering a new paradigm in "enriched" Phase 1 clinical trial services, seamlessly combining Phase 1 clinical trial services with strategic development support. Services are performed at our 16-bed, state-of-the-art facility ideally situated in Plymouth, Michigan between Ann Arbor and Detroit, and conveniently located near three major medical centers.